Error: Could not add to watchlist. X

Hemispherx Biopharma Inc

+ Watchlist
HEB:US
NYSE MKT LLC
0.200
USD
0.001
0.50%
As of 20:04:03 ET on 07/07/2015.
Open
0.190
Day Range
0.172 - 0.200
Volume
2,349,119
Previous Close
0.199
52Wk Range
0.172 - 0.400
1 Yr Return
-37.50%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.090
Market Cap (m USD)
48.511
Shares Outstanding (m)
242.555
Price/Sales (TTM)
250.53
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Hemispherx Biopharma, Inc. is a biopharmaceutical company that focuses on the development of nucleic acids to enhance the natural anti-viral defense systems of the human body. The Company's lead product, Ampligen, is undergoing clinical trials for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
ADDRESS
1617 JFK Boulevard
Suite 660
Philadelphia, PA 19103
United States
PHONE
1-215-988-0080
  • William A Carter
    Chairman/Pres/CEO
  • Thomas K Equels
    Exec Vice Chair/CFO/Secy/Gen Cnsl
  • Wayne S Springate
    Senior VP:Operations
  • David R Strayer
    Chief Medical Ofcr/Dir:Medical
Show More